| Metric | Q3 2024 | Q2 2024 | Q3 2023 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $1.5B | — | $1.5B | — | 0.4% |
| Op. Income | $30M | — | $35M | — | -12.9% |
| Gross Margin | 60.0% | — | 55.6% | — | 4.5pp |
| Net Margin | 1.4% | — | 0.6% | — | 0.7pp |
| EPS (Diluted) | $0.05 | — | $0.02 | — | 115.1% |
| Free Cash Flow | $2M | — | -$18M | — | 112.9% |
| Item | Amount |
|---|---|
| REVENUE | $1.5B |
| Cost of Revenue | $606M |
| GROSS PROFIT | $911M |
| R&D Expenses | $0 |
| Selling & Marketing | $436M |
| General & Administrative | $330M |
| SG&A Expenses | $766M |
| Other Expenses | $115M |
| Operating Expenses | $880M |
| Cost & Expenses | $1.5B |
| OPERATING INCOME | $30M |
| Interest Income | $0 |
| Interest Expense | $10M |
| Other Income/Expenses | -$11M |
| INCOME BEFORE TAX | $20M |
| Income Tax Expense | -$900.0K |
| Net Income from Continuing Ops | $21M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $21M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $21M |
| D&A | $50M |
| EBIT | $30M |
| EBITDA | $80M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $1.5B |
| Cost of Revenue | $606M |
| GROSS PROFIT | $911M |
| R&D Expenses | $0 |
| Selling & Marketing | $436M |
| General & Administrative | $330M |
| SG&A Expenses | $766M |
| Other Expenses | $115M |
| Operating Expenses | $880M |
| Cost & Expenses | $1.5B |
| OPERATING INCOME | $30M |
| Interest Income | $0 |
| Interest Expense | $10M |
| Other Income/Expenses | -$11M |
| INCOME BEFORE TAX | $20M |
| Income Tax Expense | -$900.0K |
| Net Income from Continuing Ops | $21M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $21M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $21M |
| D&A | $50M |
| EBIT | $30M |
| EBITDA | $80M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $21M |
| Depreciation & Amortization | $50M |
| Stock-Based Compensation | $13M |
| Deferred Income Tax | -$25M |
| Other Non-Cash Items | $132M |
| Change in Working Capital | -$139M |
| OPERATING CASH FLOW | $52M |
| Capital Expenditure | -$50M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | -$6M |
| Other Investing Activities | $5M |
| NET CASH FROM INVESTING | -$51M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | -$18M |
| Common Dividends Paid | -$52M |
| Other Financing Activities | $3M |
| NET CASH FROM FINANCING | -$66M |
| FREE CASH FLOW | $2M |
| Net Change in Cash | -$64M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $577M |
| Short-Term Investments | $0 |
| Net Receivables | $680M |
| Inventory | $1.3B |
| Other Current Assets | $214M |
| TOTAL CURRENT ASSETS | $2.7B |
| PP&E (Net) | $1.8B |
| Goodwill | $281M |
| Intangible Assets | $198M |
| Long-Term Investments | $0 |
| Tax Assets | $778M |
| Other Non-Current Assets | $449M |
| TOTAL NON-CURRENT ASSETS | $3.5B |
| TOTAL ASSETS | $6.3B |
| Account Payables | $668M |
| Short-Term Debt | $7M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $764M |
| TOTAL CURRENT LIABILITIES | $1.9B |
| Long-Term Debt | $1.0B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $444M |
| TOTAL NON-CURRENT LIABILITIES | $2.4B |
| TOTAL LIABILITIES | $4.4B |
| Common Stock | $400.0K |
| Additional Paid-In Capital | $720M |
| Retained Earnings | $1.6B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$419M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $1.9B |
| Minority Interest | $0 |
| TOTAL EQUITY | $1.9B |
| TOTAL LIABILITIES & EQUITY | $6.3B |
| Total Debt | $2.3B |
| Net Debt | $1.7B |
